The MHRA GPvP Inspection Metrics report for the period April 2020]}** to March 2021 is now available. Read the full metrics report published on GOV.UK. We hope that the report...
In August 2020]}** the International Coalition of Medicines Regulatory Authorities (ICMRA) established a working group to look at the move to remote inspections for GCP and GMP during the pandemic....
Between 11 and 14 February 2020]}**, the MHRA hosted a week-long series of events as part of the Good Practice Symposia Week. This included individual events from the GPvP, GCP...
https://youtu.be/I3CkPHWQI8M Post-transition: Pharmacovigilance requirements for UK authorised products webinar recording, which took place on 22 October 2020]}**. This webinar was part of a series of EU Exit and post-transition guidance...
On 23rd March 2020]}** I published a post outlining changes to MHRA’s GxP inspection programme during the COVID19 outbreak. This enabled industry and the NHS to focus on medicine supply...
Between 11 and 14 February 2020]}**, the MHRA hosted a week-long series of events as part of the Good Practice Symposia Week. This included individual events from the GPvP, GCP...
Since before the end of the transition period on 31 December 2020]}**, we have been working hard to provide the guidance you need to become familiar with the pharmacovigilance requirements...
...been encouraging to see industry stakeholders and regulatory partners adopting a common approach in their own publications and the messages and themes being echoed in online discussions, workshops and conference...
...15mg, 30mg or 60mg. For Tramadol, just Tramadol Hydrochloride, tablets or capsules. No return is required for any mixed API products. A big thank you to the companies providing this...
...was the start of my journey. The application process is designed to not only challenge your experience and knowledge, but also to look at your personality profile. After several online...
